Explore the economic perspectives of cost and coverage in genomic testing medicine through this informative webinar. Delve into terms and analytical methods used for evaluating healthcare interventions economically, and understand how US public and private payers consider cost and effectiveness information when making value-based coverage and reimbursement decisions. Learn about the implications for adopting new genomic technologies in clinical practice. Gain insights from Scott Grosse, PhD, a senior health economist at the CDC, as he shares his expertise on rare disorders, neurodevelopmental disorders, and public health strategies. Discover various economic evaluation methods, including cost-effectiveness analysis and budgetary impact analysis. Understand the concept of QALYs and how to assess cost-effectiveness or cost savings by comparing different strategies. Examine Medicare coverage of genomic tests and counseling, particularly for hereditary cancers. Investigate the cost-effectiveness of genetic testing for hereditary cancers, including tumor testing for Lynch syndrome in newly diagnosed colorectal cancer patients. Read more